NCT04329221 2025-05-07
Immunotherapy Before Transplantation for Skin Cancer Prevention in Organ Transplant Recipients
Massachusetts General Hospital
Phase 2 Withdrawn
Clinical Trials
13 trialsNCT04642287 2025-05-07
Immunotherapy After Transplantation for Skin Cancer Prevention in Organ Transplant Recipients
Massachusetts General Hospital
Phase 2 Withdrawn
NCT06207786 2024-11-25
Nasal Iodine Swab Versus Oral Antibiotic to Prevent Surgical Site Infection After Undergoing Mohs Micrographic Surgery
Mayo Clinic
Phase NA Withdrawn
NCT06638736 2024-10-15
A Randomized Controlled Trial Comparing Sutures vs Staples for High Tension Closures
University of Kansas Medical Center
Phase NA Withdrawn
NCT05643755 2024-04-08
Preoperative Image-based Education Effect on Postoperative Satisfaction of Patients Undergoing First-time Dermatologic Surgery
Johns Hopkins University
Phase NA Withdrawn
NCT04176900 2023-10-02
3D Printed Rigid Bolus Versus Silicone Bolus for Treatment of Tumors Involving the Skin: A Comparative Study
Nova Scotia Cancer Centre
Phase NA Withdrawn
NCT04127318 2022-09-23
Low-moderate Intensity Pedaling During Immunotherapy Administration
Rush University Medical Center
Phase NA Withdrawn
NCT03972046 2020-10-19
Neoadjuvant Use of Talimogene Laherparepvec and BRAF/MEK Inhibitor for Advanced Nodal BRAF Mutant Melanoma
TriHealth Inc.
Phase 2 Withdrawn
NCT03485937 2019-10-22
Impact of Videos on Patient Anxiety and Satisfaction
Case Comprehensive Cancer Center
Phase NA Withdrawn
NCT03282188 2018-05-04
REO13 Melanoma With of Without GM-CSF
University of Leeds
Phase 1/2 Withdrawn
NCT02061007 2016-05-09
Biomarker Correlates of Hypoxia in Metastatic Melanoma
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Withdrawn
NCT02507076 2015-07-23
Isolated Limb Perfusion With Melphalan in Treating Patients With Stage IIIB-IV Melanoma or Sarcoma
Albert Einstein College of Medicine
Phase NA Withdrawn
NCT01465815 2014-11-19
Phase I/II Study of Postoperative Adjuvant Chemoradiation for Advanced-Stage Cutaneous Squamous Cell Carcinoma of the Head and Neck (cSCCHN)
OHSU Knight Cancer Institute
Phase 1/2 Withdrawn